首頁 > 市場調查報告書 > 醫療設備

生物材料

市場調查報告書

商品編碼

1391962

神經再生治療市場：按神經再生治療類型、按適應症、按給藥方法、按年齡層、按最終用戶、按地區

Neuroregeneration Therapy Market, By Type of Neuroregeneration Therapy, By Indication, By Mode of Administration, By Age Group, By End User, By Geography

出版日期: 2023年11月01日 | 出版商:

Coherent Market Insights | 英文 161 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計2023年全球神經再生治療市場規模為116.7億美元，預計2030年將達266.1億美元，2023年至2030年年複合成長率為12.5%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	116.7億美元
實績資料	2018-2021	預測期	2023-2030
預測期年複合成長率	12.50%	2030年市場規模預測	266.1億美元

圖 1. 2023 年神經再生療法的全球市場佔有率（按地區分類）

神經再生是指神經元、軸突、突觸、神經膠質細胞等神經組織的再生或修復過程。這個過程對於替換因損傷而受損的組織並確保長期功能恢復至關重要。新的神經元和連結被合成，提供新的資源來取代受損的神經元。神經再生不僅是身體恢復的重要機制，也是維持認知功能的重要機制。它在對抗記憶喪失和老齡化相關異常方面發揮著重要作用。神經再生的藥理刺激可以恢復認知功能，提升記憶力和其他認知能力。總之，神經再生是一個重要的生物過程，對於治療各種神經系統疾病和促進大腦健康具有重要意義。

市場動態：

由於幾個關鍵因素，預計全球神經再生治療市場在未來幾年將顯著成長。首先，神經系統疾病（包括中樞和周邊神經系統疾病）的盛行率不斷增加，對有效和安全的治療提出了很高的需求。這些疾病可能對患者的生活造成嚴重影響，因此對神經再生治療的需求變得極為重要。其次，世界人口高齡化迅速加劇。老年人更容易患神經系統疾病，進一步增加了對這些治療方法的需求。隨著人們尋求改善生活品質的治療方法，神經再生療法市場預計將會成長。最後，神經再生領域的研究和開發活動正在迅速增加。科學家和研究人員不斷探索新的治療方法，並在了解如何刺激神經組織修復和再生方面取得突破。這種持續的創新預計將為市場帶來新的治療方法並推動進一步成長。總而言之，高疾病負擔、高齡化以及積極的研發正在推動全球神經再生治療市場向前發展。

例如，2023年2月6日，生物技術公司Biogen Inc.和Sage Therapeutics, Inc.獲得美國食品藥物管理局（FDA）批准用於治療重度憂鬱症（MDD）和產後憂鬱症（PPD）。該公司已收到zuranolone 的新藥認證申請（NDA）。 Zuranolone 是一種臨床實驗藥物，正在評估為每日一次、為期 14 天的快速起效口服療法，用於治療成人 MDD 和 PPD。

本研究的主要特點

本報告對全球神經再生治療市場進行了詳細分析，並列出了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率。
它還揭示了各個細分市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
它根據以下參數（例如公司亮點、產品系列、主要亮點、財務實績和策略）介紹了全球神經再生治療市場的主要企業。
該報告的見解將使行銷人員和公司負責人能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出資訊的決策。
神經再生療法的全球市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析全球神經再生治療市場的各種策略矩陣，將促進相關人員的決策。

介紹
北美洲
美國
加拿大
歐洲
德國
英國
西班牙
法國
義大利
俄羅斯
歐洲其他地區
亞太地區
中國
印度
日本
澳洲
韓國
東南亞國協
其他亞太地區
拉丁美洲
巴西
阿根廷
墨西哥
其他拉丁美洲
中東
海灣合作理事會國家
以色列
其他中東地區
非洲
南非
北非
中部非洲

第11章競爭形勢

Biogen Inc.
AstraZeneca PLC
Pfizer Inc.
Novartis International AG
Merck & Co., Inc.
Sanofi SA
F. Hoffmann-La Roche Ltd.
Medtronic plc
Boston Scientific Corporation
Abbott Laboratories
Ceregene Inc.
Lineage Cell Therapeutics, Inc.
Stemedica Cell Technologies, Inc.
StemCells Inc.
Ever Supreme Bio Technology Co., Ltd.
AbbVie

第12章章節

調查方法
關於出版商

簡介目錄

Product Code: CMI5837

Global neuroregeneration therapy market size is estimated to be valued at US$ 11.67 Bn in 2023, and is expected to reach US$ 26.61 Bn by 2030, exhibiting a compound annual growth rate (CAGR) of 12.5% from 2023 to 2030.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 11.67 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	12.50%	2030 Value Projection:	US$ 26.61 Bn

Figure 1. Global Neuroregeneration Therapy Market Share (%),By Region, 2023

Neuroregeneration refers to the process of regenerating or repairing nervous tissue, including neurons, axons, synapses, and glial cells. This process is crucial for replacing damaged tissues due to injury and ensuring long-term functional recovery. It involves the synthesis of new neurons and connections, providing additional resources to substitute the damaged ones. Neuroregeneration is not just about physical recovery; it's also a vital mechanism for maintaining cognitive functions. It plays a significant role in combating memory disorders and abnormalities related to aging. By pharmacologically stimulating neuroregeneration, it's possible to rescue cognitive functions, thereby improving memory and other cognitive abilities. In essence, neuroregeneration is a critical biological process with significant implications for treating various neurological conditions and improving brain health.

Market Dynamics:

The global neuroregeneration therapy market is expected to witness significant growth in the coming years, driven by several key factors. Firstly, the increasing prevalence of neurological disorders, including both central and peripheral nervous system disorders, is creating a high demand for effective and safe treatments. These disorders can have a debilitating impact on patients' lives, making the need for neuroregenerative therapies crucial. Secondly, the world's aging population is growing rapidly. Older individuals are more susceptible to neurological conditions, which further increases the demand for these therapies. As people seek treatments that can improve their quality of life, the market for neuroregeneration therapies is expected to expand. Lastly, there is a surge in research and development activities in the field of neuroregeneration. Scientists and researchers are continually exploring new treatment methods and making breakthroughs in understanding how to stimulate the repair and regrowth of nervous tissue. This ongoing innovation is expected to introduce new therapies to the market, driving further growth. In summary, the combination of a high disease burden, an aging population, and active research and development are set to propel the global neuroregeneration therapy market forward.

For instance, on February 6, 2023, Biogen Inc., a biotechnology company, and Sage Therapeutics, Inc., a biotechnology company, announced that the U.S. Food and Drug Administration (FDA) had accepted the filing of a New Drug Application (NDA) for zuranolone in the treatment of major depressive disorder (MDD) and postpartum depression (PPD). Zuranolone is an investigational drug being evaluated as a 14-day, rapid-acting, once-daily, oral treatment in adults with MDD and PPD.

Key features of the study:

This report provides in-depth analysis of the global neuroregeneration therapy market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global neuroregeneration therapy market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Biogen Inc., AstraZeneca PLC, Pfizer Inc., Novartis International AG, Merck & Co., Inc., Sanofi S.A., F. Hoffmann-La Roche Ltd., Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Ceregene Inc., Stemedica Cell Technologies, Inc., Lineage Cell Therapeutics, Inc., StemCells Inc., Ever Supreme Bio Technology Co., Ltd. and AbbVie
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global neuroregeneration therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neuroregeneration therapy market

Detailed Segmentation:

By Type of Neuroregeneration Therapy:
- Stem Cell Therapy
- Gene Therapy
- Pharmacological Therapy
- Neurostimulation Therapy
- Others
By Indication:
- Spinal Cord Injury
- Stroke
- Traumatic Brain Injury
- Parkinson's Disease
- Alzheimer's Disease
- Multiple Sclerosis
- Peripheral Nerve Injury
- Others
By Mode of Administration:
- Oral
- Injectable
- Implantable
- Others
By Age Group:
- Pediatric
- Adult
- Geriatric
By End User:
- Hospitals
- Specialty Clinics
- Research Institutes
- Rehabilitation Centers
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Biogen Inc.
- AstraZeneca PLC
- Pfizer Inc.
- Novartis International AG
- Merck & Co., Inc.
- Sanofi S.A.
- F.Hoffmann-La Roche Ltd.
- Medtronic plc
- Boston Scientific Corporation
- Abbott Laboratories
- Ceregene Inc.
- Lineage Cell Therapeutics, Inc.
- Stemedica Cell Technologies, Inc.
- StemCells Inc.
- Ever Supreme Bio Technology Co., Ltd.
- AbbVie

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Type of Neuroregeneration Therapy
- Market Snippet, By Indication
- Market Snippet, By Mode of Administration
- Market Snippet, By Age Group
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Growing burden of neurological disorders
- High cost and dearth of skilled professionals
- High demand for safe and effective therapeutics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Neuroregeneration Therapy Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Neuroregeneration Therapy Market, By Type of Neuroregeneration Therapy, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 - 2030
- Segment Trends
Stem Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Pharmacological Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Neurostimulation Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Neuroregeneration Therapy Market, By Indication, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Spinal Cord Injury
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Stroke
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Traumatic Brain Injury
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,( US$ Bn)
Parkinson's Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Alzheimer's Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Multiple Sclerosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030 ,(US$ Bn)
Peripheral Nerve Injury
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Neuroregeneration Therapy Market, By Mode of Administration, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Implantable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Other
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Neuroregeneration Therapy Market, By Age Group, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

9. Global Neuroregeneration Therapy Market, By End User, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Rehabilitation Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

10. Global Neuroregeneration Therapy Market, By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Neuroregeneration Therapy, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
South Africa
North Africa
Central Africa

11. Competitive Landscape

Biogen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
AstraZeneca PLC
Pfizer Inc.
Novartis International AG
Merck & Co., Inc.
Sanofi S.A.
F. Hoffmann-La Roche Ltd.
Medtronic plc
Boston Scientific Corporation
Abbott Laboratories
Ceregene Inc.
Lineage Cell Therapeutics, Inc.
Stemedica Cell Technologies, Inc.
StemCells Inc.
Ever Supreme Bio Technology Co., Ltd.
AbbVie
Analyst Views